Analyze Diet
BMC research notes2012; 5; 626; doi: 10.1186/1756-0500-5-626

Crystal structures of wild-type and mutated cyclophilin B that causes hyperelastosis cutis in the American quarter horse.

Abstract: Hyperelastosis cutis is an inherited autosomal recessive connective tissue disorder. Affected horses are characterized by hyperextensible skin, scarring, and severe lesions along the back. The disorder is caused by a mutation in cyclophilin B. Results: The crystal structures of both wild-type and mutated (Gly6->Arg) horse cyclophilin B are presented. The mutation neither affects the overall fold of the enzyme nor impairs the catalytic site structure. Instead, it locally rearranges the flexible N-terminal end of the polypeptide chain and also makes it more rigid. Conclusions: Interactions of the mutated cyclophilin B with a set of endoplasmic reticulum-resident proteins must be affected.
Publication Date: 2012-11-08 PubMed ID: 23137129PubMed Central: PMC3522003DOI: 10.1186/1756-0500-5-626Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article investigates how a genetic mutation in American Quarter Horses impacts the function of a protein called cyclophilin B, which is essential to the proper folding of collagen in the body. The resulting disease, hyperelastosis cutis, causes changes in the structure of collagen fibres in the horse’s tendon.

Mutation in Cyclophilin B

  • The research examines the impact of the G6R mutation in cyclophilin B, a protein, in American Quarter Horses. This genetic mutation leads to a disease known as hyperelastosis cutis, also known as hereditary equine regional dermal asthenia (HERDA).
  • The mutated protein demonstrates minor structural changes in the area of the mutation, on the side opposite to the catalytic (active) domain of cyclophilin B.

Effects on Peptidylprolyl Cis-Trans Isomerase Activity

  • Despite the mutation, the peptidylprolyl cis-trans isomerase activity (the ability to accelerate the folding of proteins) of the mutant Cyclophilin B remains normal when studied in an in vitro (lab) setting.

Effects on Type I Collagen Synthesis

  • However, the biosynthesis (natural production) of type I collagen in the fibroblasts (cells responsible for producing connective tissue) of the affected horses reveals a delay in protein folding and secretion.
  • Additionally, there is a reduction in two compounds – hydroxylysine and glucosyl-galactosyl – hydroxylysine. As a result, there are changes in the structure of the collagen fibrils in the tendons of the horses – similar to what is observed in P3H1 null mice.

Disruption to Protein Interactions

  • The mutation disrupts the interaction between cyclophilin B and other proteins such as the P-domain of calreticulin and lysyl hydroxylase 1. The mutation may also affect interactions with the P3H1·CypB·cartilage-associated protein complex.
  • This results in less effective catalysis (the acceleration of a chemical reaction) of the rate-limiting step (the slowest step) in collagen folding in the rough endoplasmic reticulum (part of the cell where protein synthesis occurs).

Difference from Cyclophilin B Null Mice

  • In comparison to cyclophilin B null mice, where low levels of 3-hydroxylation are found in Type I collagen, 3-hydroxylation of Type I collagen in the affected horses remains normal.

Cite This Article

APA
Boudko SP, Ishikawa Y, Lerch TF, Nix J, Chapman MS, Bächinger HP. (2012). Crystal structures of wild-type and mutated cyclophilin B that causes hyperelastosis cutis in the American quarter horse. BMC Res Notes, 5, 626. https://doi.org/10.1186/1756-0500-5-626

Publication

ISSN: 1756-0500
NlmUniqueID: 101462768
Country: England
Language: English
Volume: 5
Pages: 626

Researcher Affiliations

Boudko, Sergei P
  • Research Department, Shriners Hospital for Children, Portland, OR 97239, USA.
Ishikawa, Yoshihiro
    Lerch, Thomas F
      Nix, Jay
        Chapman, Michael S
          Bächinger, Hans Peter

            MeSH Terms

            • Animals
            • Crystallography, X-Ray
            • Cyclophilins / chemistry
            • Cyclophilins / genetics
            • Horse Diseases / enzymology
            • Horse Diseases / genetics
            • Horses
            • Models, Molecular
            • Mutation, Missense
            • Protein Structure, Secondary
            • Protein Structure, Tertiary
            • Skin / enzymology
            • Skin / metabolism
            • Skin / pathology
            • Skin Diseases / enzymology
            • Skin Diseases / genetics
            • Skin Diseases / veterinary

            Grant Funding

            • T32AI007472 / NIAID NIH HHS

            References

            This article includes 22 references
            1. White SD, Affolter VK, Bannasch DL, Schultheiss PC, Hamar DW, Chapman PL, Naydan D, Spier SJ, Rosychuk RA, Rees C. Hereditary equine regional dermal asthenia (“hyperelastosis cutis”) in 50 horses: clinical, histological, immunohistological and ultrastructural findings.. Vet Dermatol 2004;15(4):207–217.
            2. Mao JR, Bristow J. The Ehlers-Danlos syndrome: on beyond collagens.. J Clin Invest 2001;107(9):1063–1069.
              doi: 10.1172/JCI12881pmc: PMC209288pubmed: 11342567google scholar: lookup
            3. Tryon RC, White SD, Bannasch DL. Homozygosity mapping approach identifies a missense mutation in equine cyclophilin B (PPIB) associated with HERDA in the American Quarter Horse.. Genomics 2007;90(1):93–102.
              doi: 10.1016/j.ygeno.2007.03.009pubmed: 17498917google scholar: lookup
            4. Price ER, Zydowsky LD, Jin MJ, Baker CH, McKeon FD, Walsh CT. Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence.. Proc Natl Acad Sci USA 1991;88(5):1903–1907.
              doi: 10.1073/pnas.88.5.1903pmc: PMC51134pubmed: 2000394google scholar: lookup
            5. Hasel KW, Glass JR, Godbout M, Sutcliffe JG. An endoplasmic reticulum-specific cyclophilin.. Mol Cell Biol 1991;11(7):3484–3491.
              pmc: PMC361082pubmed: 1710767
            6. Steinmann B, Bruckner P, Superti-Furga A. Cyclosporin A slows collagen triple-helix formation in vivo: indirect evidence for a physiologic role of peptidyl-prolyl cis-trans-isomerase.. J Biol Chem 1991;266(2):1299–1303.
              pubmed: 1985948
            7. van Dijk FS, Nesbitt IM, Zwikstra EH, Nikkels PG, Piersma SR, Fratantoni SA, Jimenez CR, Huizer M, Morsman AC, Cobben JM. PPIB mutations cause severe osteogenesis imperfecta.. Am J Hum Genet 2009;85(4):521–527.
              doi: 10.1016/j.ajhg.2009.09.001pmc: PMC2756556pubmed: 19781681google scholar: lookup
            8. Choi JW, Sutor SL, Lindquist L, Evans GL, Madden BJ, Bergen HR 3rd, Hefferan TE, Yaszemski MJ, Bram RJ. Severe osteogenesis imperfecta in cyclophilin B-deficient mice.. PLoS Genet 2009;5(12):e1000750.
            9. Forlino A, Cabral WA, Barnes AM, Marini JC. New perspectives on osteogenesis imperfecta.. Nat Rev Endocrinol 2011;7(9):540–557.
              doi: 10.1038/nrendo.2011.81pmc: PMC3443407pubmed: 21670757google scholar: lookup
            10. Vranka JA, Sakai LY, Bächinger HP. Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes.. J Biol Chem 2004;279(22):23615–23621.
              doi: 10.1074/jbc.M312807200pubmed: 15044469google scholar: lookup
            11. Ishikawa Y, Wirz J, Vranka JA, Nagata K, Bächinger HP. Biochemical characterization of the prolyl 3-hydroxylase 1.cartilage-associated protein.cyclophilin B complex.. J Biol Chem 2009;284(26):17641–17647.
              doi: 10.1074/jbc.M109.007070pmc: PMC2719403pubmed: 19419969google scholar: lookup
            12. Braakman I, Bulleid NJ. Protein folding and modification in the mammalian endoplasmic reticulum.. Annu Rev Biochem 2011;80:71–99.
            13. Jansen G, Maattanen P, Denisov AY, Scarffe L, Schade B, Balghi H, Dejgaard K, Chen LY, Muller WJ, Gehring K. An interaction map of ER chaperones and foldases.. Mol Cell Proteomics 2012;11(9):710–723.
              doi: 10.1074/mcp.M111.016550pmc: PMC3434782pubmed: 22665516google scholar: lookup
            14. Kozlov G, Bastos-Aristizabal S, Maattanen P, Rosenauer A, Zheng F, Killikelly A, Trempe JF, Thomas DY, Gehring K. Structural basis of cyclophilin B binding by the calnexin/calreticulin P-domain.. J Biol Chem 2010;285(46):35551–35557.
              doi: 10.1074/jbc.M110.160101pmc: PMC2975179pubmed: 20801878google scholar: lookup
            15. Ishikawa Y, Vranka JA, Boudko SP, Pokidysheva E, Mizuno K, Zientek K, Keene DR, Rashmir-Raven AM, Nagata K, Winand NJ. The mutation in cyclophilin B that causes hyperelastosis cutis in the American Quarter Horse does not affect peptidyl-prolyl cis-trans isomerase activity, but shows altered cyclophilin B-protein interactions and affects collagen folding.. J Biol Chem 2012;287:22253–22265.
              doi: 10.1074/jbc.M111.333336pmc: PMC3381186pubmed: 22556420google scholar: lookup
            16. Pehar M, Lehnus M, Karst A, Puglielli L. Proteomic assessment shows that many endoplasmic reticulum (ER)-resident proteins are targeted by N(epsilon)-lysine acetylation in the lumen of the organelle and predicts broad biological impact.. J Biol Chem 2012;287(27):22436–22440.
              doi: 10.1074/jbc.C112.362871pmc: PMC3391156pubmed: 22628546google scholar: lookup
            17. Collaborative Computational Project N. The CCP4 suite: programs for protein crystallography.. Acta Crystallogr D: Biol Crystallogr 1994;50(Pt 5):760–763.
              pubmed: 15299374
            18. Mikol V, Kallen J, Walkinshaw MD. X-ray structure of a cyclophilin B/cyclosporin complex: comparison with cyclophilin A and delineation of its calcineurin-binding domain.. Proc Natl Acad Sci USA 1994;91(11):5183–5186.
              doi: 10.1073/pnas.91.11.5183pmc: PMC43956pubmed: 8197205google scholar: lookup
            19. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot.. Acta Crystallogr D: Biol Crystallogr 2010;66(Pt 4):486–501.
              pmc: PMC2852313pubmed: 20383002
            20. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW. PHENIX: a comprehensive Python-based system for macromolecular structure solution.. Acta Crystallogr D: Biol Crystallogr 2010;66(Pt 2):213–221.
              pmc: PMC2815670pubmed: 20124702
            21. McNicholas S, Potterton E, Wilson KS, Noble ME. Presenting your structures: the CCP4mg molecular-graphics software.. Acta Crystallogr D: Biol Crystallogr 2011;67(Pt 4):386–394.
              pmc: PMC3069754pubmed: 21460457
            22. Chen VB, Arendall WB 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC. MolProbity: all-atom structure validation for macromolecular crystallography.. Acta Crystallogr D Biol Crystallogr 2010;66(Pt 1):12–21.
              pmc: PMC2803126pubmed: 20057044

            Citations

            This article has been cited 1 times.
            1. Ishikawa Y, Bächinger HP. A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis. J Biol Chem 2014 Jun 27;289(26):18189-201.
              doi: 10.1074/jbc.M114.561944pubmed: 24821723google scholar: lookup